Boni Elewski, MD, a professor and chair of dermatology at the University of Alabama in Birmingham, Alabama, discusses the characteristics and diagnosis of generalized pustular psoriasis (GPP). She notes that GPP is often characterized by large pustules on multiple body areas, often triggered by antibiotics, steroids, or infections. Currently, the only available treatment approved by the FDA is spesolimab (Spevigo), which has shown to be highly effective in specialized treatment for these flares, demonstrating rapid skin and pustular clearance.
Topics Covered:
- Alternative treatment regimens and precautions
- Diagnosis and differential diagnosis in patients with GPP
- Management of acute and recurrent GPP
Explore Related Resources:
Scott Worswick, MD: Dosing Strategies for Treating Generalized Pustular Psoriasis
James Song, MD, FAAD: Assessing Systemic GPP Treatment With Targeted Therapy
